Novan Therapeutics' Series D - II Round

Novan Therapeutics raised a round of funding on March 30, 2015.

Novan is a clinical-stage drug development company aiming to commercialize nitric oxide-based products in selected therapeutic areas. The Company's core technologies solve the delivery issues with nit…

Articles about Novan Therapeutics' Series D - II Round: